IRENE study: Phase 2 study of INCMGA00012 (retifanlimab) and the oncolytic virus pelareorep in metastatic triple negative breast cancer

George et al, Previously presented at the 2020 Virtual San Antonio Breast Cancer Symposium® – 43rd Annual Meeting;  San Antonio, TX, USA; December 9-11, 2020